Living

Lilly to acquire three vaccine developers for $4 billion

By Reuters Reuters
The Eli Lilly logo appears on one of the company's offices in San Diego, California, U.S., November 21, 2025. REUTERS/Mike Blake
The Eli Lilly logo appears on one of the company's offices in San Diego, California, U.S., November 21, 2025. REUTERS/Mike Blake Mike Blake Reuters

Eli Lilly said on Tuesday it will buy three vaccine developers in deals worth up to nearly $4 billion in combined value, signaling a push by the drugmaker into infectious disease prevention.

(Reporting by Sriparna Roy in Bengaluru; Editing by Shinjini Ganguli)

Copyright Reuters or USA Today Network via Reuters Connect

This story was originally published May 26, 2026 at 3:50 AM.

Get one year of unlimited digital access for $159.99
#ReadLocal

Only 44¢ per day

SUBSCRIBE NOW